90 Startups
  • Sector
  • Participated in
  • Year of participation

River Biomedics

  • 2018
  • Enabling Technology
  • Venture Challenge
River BioMedics offers new human cardiac 3D models for target validation during drug discovery. Our 3D models are scalable to high-throughput and provide clinically relevant cardiac readouts for reliable drug efficacy validation.

Scope Biosciences

  • 2020
  • Diagnostics
  • Venture Challenge
CRISPR-Cas has revolutionized the field of gene editing and will also disrupt the field of molecular diagnostics. CRISPR diagnostics (CRISPR-Dx), combined with a pre-amplification step, are faster and easier than (q)PCR whilst obtaining results of the same quality.

Self-Screen

  • 2010
  • Diagnostics
  • Other
Development and clinical application of molecular assays for the early detection of cancer

SeraNovo

  • 2018
  • Enabling Technology
  • Venture Challenge
SeraNovo’s proprietary formulation platform radically increases bioavailability and allows products to reach the market significantly quicker, at a lower cost.

ShanX Medtech

  • 2020
  • Diagnostics
  • Venture Challenge
Providing a reliable UTI diagnosis and simultaneously indicating the optimal antibiotic prescription in under 4 hours

Sirius Medical

  • 2015
  • Medical Device
  • Venture Challenge
The next generation of accurate and hassle-free tumor localization for breast cancer.

SLAM Orthopedic

  • 2020
  • Medical Device
  • Venture Challenge
SLAM Ortho has developed an automated, accurate and fast bore depth measurement system. It is compatible with the currently used drill machines and drill bits. This leads to: No time lost in (repeated) measurements, no extra x-rays needed, no wasted implants, no extra actions needed and a decreased risk of re-surgery for the patient.

STENTiT

  • 2016
  • Medical Device
  • Venture Challenge
To become the new standard in vascular treatment. By bringing regenerative capacity for the first time to a stent, a wide range of clinical applications will benefit from our innovative approach.

SyCap

  • 2018
  • Medical Device
  • Venture Challenge
Provide pain relief and functional restoration for patients suffering from focal knee cartilage defects, which is a chronic and severely disabling musculoskeletal condition.

T-Cell Factory

  • 2013
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
T Cell Factory (TCF) will identify and develop therapeutic T cell receptor (TCR) genes for the growing market of cancer therapies.